
Adult Immunization
Latest News

Telehealth Mindfulness Program Linked to Sustained Low Back Pain Improvements

FDA Authorizes Modified Risk Claim for ZYN Nicotine Pouches

Cognitive Rehabilitation Linked to Functional Gains in Long COVID Trial

5 FDA Decisions for Primary Care to Know from June 2026

FDA Expands Roflumilast Cream 0.3% Approval for Plaque Psoriasis in Children Aged 2 Years and Older

Shorts










Latest Videos
All News

FDA approved risankizumab for children aged 6 years or older with moderate to severe plaque psoriasis or active psoriatic arthritis.

Centanafadine XR improved adult ADHD symptoms in a phase 3b trial of patients with comorbid generalized or social anxiety disorder.

SLEEP 2026: Ashesha Mechineni, MD, discusses what the emerging pharmacotherapy pipeline means for clinicians.

Survey finds 18 million women 45–64 overdue for cancer screening, led by colorectal gaps—bundled reminders could

New data show why earlier, intensive LDL-C lowering matters

Social, behavioral, and environmental factors improved risk prediction beyond genetic scores for 6 common diseases in All of Us data.

The CRL cites deficiencies at a third-party manufacturing facility, with no efficacy or clinical safety deficiencies identified.

SLEEP 2026: GLP-related home sleep testing made up 44% of primary care referrals, but many studies were negative or suboptimal, according to a late-breaking abstract.

FDA approved teplizumab to help preserve insulin production in children with recent-onset stage 3 type 1 diabetes.







































































































































































































